| Identification | Back Directory | [Name]
2-Propen-1-one, 1-(4-bromophenyl)-3-(4-fluorophenyl)- | [CAS]
98991-32-3 | [Synonyms]
CHBO4 1-(4-bromophenyl)-3-(4-fluorophenyl)prop-2-en-1-one 2-Propen-1-one, 1-(4-bromophenyl)-3-(4-fluorophenyl)- (2E)-1-(4-bromophenyl)-3-(4-fluorophenyl)prop-2-en-1-one | [Molecular Formula]
C15H10BrFO | [MDL Number]
MFCD00446111 | [MOL File]
98991-32-3.mol | [Molecular Weight]
305.14 |
| Hazard Information | Back Directory | [Uses]
CHBO4 is a potent, reversible, competitive, and selective hMAO-B inhibitor with an IC50 value of 0.031 μM in CHBO subseries and an Ki value of 0.010 ± 0.005 μM. CHBO4 reduce cell damage by scavenging intracellular reactive oxygen species (ROS). CHBO4 can be used for Parkinson's Disease (PD) research[1]. | [IC 50]
hMAO-B: 0.031 μM (IC50); hMAO-B: 0.010 μM (Ki) | [References]
[1] Thomas Parambi DG, et al. Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study. Comput Biol Chem. 2023 Aug;105:107899. DOI:10.1016/j.compbiolchem.2023.107899 |
|
| Company Name: |
Bide Pharmatech Ltd.
|
| Telephone: |
400-1647117 13681763483 |
| Website: |
https://www.bidepharm.com/ |
| Company Name: |
InvivoChem
|
| Telephone: |
13549236410 |
| Website: |
https://www.invivochem.cn/ |
|